Health
First Randomized Trial Reassures on ACEIs, ARBs in COVID-19 – Medscape
The BRACE CORONA study found no difference in key outcomes between patients continuing vs stopping their medication.
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.
The first randomized study to compare continuing vs stopping angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) for patients with COVID-19 has shown no difference in key outcomes between the two approaches.
The BRACE CORONA trial conducted in patients had been taking an ACE inhibitor or an ARB on a long-term basis and who were subsequently hospitalized with C…
-
Noosa News16 hours agoThe grey backstreet of Brisbane’s Fortitude Valley where Arnie the missing dog was found dead in his owner Nathan McKeown’s black ute
-
Noosa News23 hours agoIpswich landmark shuts down after 50 years due to storms, costs and lack of new movies
-
Noosa News18 hours agoFuel tanker racing to unload in Darwin ahead of Tropical Cyclone Fina
-
Noosa News16 hours agoShattered families demand justice after Wieambilla killers not deemed terrorists